Sabine Brookman-May/X
Apr 30, 2025, 04:09
Sabine Brookman-May: Excellent Bladder Cancer session at AUA25
Sabine Brookman-May, Senior Vice President and Therapeutic Area Head Urologic Oncology at Aura Biosciences, posted on X:
“Excellent Bladder Cancer session.
Important results on 2nd TURBT:
-
high residual tumor rates and upstaging rates.
-
important to do first TURBT right in the first place.
-
RWD like these are important to draw conclusions and improve outcomes.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 21, 2025, 21:13
May 21, 2025, 19:10
May 21, 2025, 18:49
May 21, 2025, 18:11
May 21, 2025, 18:05
May 21, 2025, 18:02